BGIM
MRK icon

Boussard & Gavaudan Investment Management’s Merck MRK Stock Holding History

Boussard & Gavaudan Investment Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-399,026
Closed -$30K – 150
2021
Q3 		$30K Buy
399,026
+28,175
+8% +$2.14M 2.53% 9
2021
Q2 		$28.9M Buy
370,851
+112,982
+44% +$8.4M 2.74% 10
2021
Q1 		$19M Buy
+257,869
New +$19M 1.84% 10

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boussard & Gavaudan Investment Management's MRK Position: Q4 2021 in Review

Boussard & Gavaudan Investment Management sold out of Merck (MRK) in Q4 2021, closing a stake of 399,026 shares — an estimated $30K sold.

Boussard & Gavaudan Investment Management first reported a position in MRK in Q1 2021 and held it in 3 quarters. The position peaked at $28.9M in Q2 2021. 2,904 funds tracked by Wall St. Rank hold MRK as of Q4 2021.

  • Boussard & Gavaudan Investment Management reported no remaining Merck position as of Q4 2021 after selling out during the quarter.
  • Boussard & Gavaudan Investment Management sold 399,026 Merck shares in Q4 2021, an estimated $30K.
  • Boussard & Gavaudan Investment Management first reported a position in Merck in Q1 2021 and held it in 3 quarters.
  • Boussard & Gavaudan Investment Management's Merck position peaked at $28.9M in Q2 2021.
  • 2,904 funds tracked by Wall St. Rank held Merck as of Q4 2021.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q4 2021, filed 10 Feb 2022.